Random

FDA

fda safety update, pills

MedShadow Articles

FDA Side Effects Update: Jylamvo, Limbitrol, Liptruzet, and More

FDA: Why Drugs Should Take A Long Time To Get To Market

FDA: Why Drugs Should Take A Long Time To Get To Market

Suzanne B. Robotti

Episode 2: Talking About FDA 'Right to Try' Laws

Episode 2: Talking About FDA ‘Right to Try’ Laws

Medshadow Staff

Clinical Trial Research Phase Studies

Clinical Trial Research Phase Studies

Medshadow Staff

FDA Approves Radicava, First New ALS Drug In More Than 2 Decades

FDA Approves Radicava, First New ALS Drug In More Than 2 Decades

FDA

Dear FDA: Do More When Nuplazid Has Issue After FDA Approval

Free Speech vs. Safe Drugs

Drug Interactions/Side Effects

Free Speech vs. Safe Drugs

Suzanne B. Robotti

FDA Approves Xiidra, A New Rx Drops For Dry Eye Disease

Issues Related to Healthcare News FDA

FDA Approves Xiidra, A New Rx Drops For Dry Eye Disease

Finally! FDA Approves Rule To Regulate E-Cigarettes

E-Cigarette News

Finally! FDA Approves Rule To Regulate E-Cigarettes

FDA Drug Recalls and Warnings: Recalls for ADHD Meds and Acne Treatments, doctor looking at computer

FDA Drug Recalls and Warnings: Recalls for ADHD Meds and Acne Treatments, Plus More

Required Postmarketing Studies For New Drugs

Required Postmarketing Studies For New Drugs

FDA Strengthens Warnings on Anemia Drug Feraheme

FDA SIDE EFFECTS UPDATE: GLP-1 Drugs And The Risk Of Serious Breathing Complications

MedShadow Articles

FDA Side Effects Update: GLP-1 Drugs and Breathing Risks

The Price of Fighting Opioid Addiction With Drugs

The Price of Fighting Opioid Addiction With Drugs

Sunscreen and Skin Absorption

Sunscreen and Skin Absorption

Suzanne B. Robotti

Differin

Healthy Skeptic new

Differin: The Price of Beauty

Suzanne B. Robotti

NSAID Side Effects Lead To Stronger FDA Warnings

NSAID Side Effects Lead To Stronger FDA Warnings

Open Letter to the FDA: You’re Protecting the Wrong People

Su Calls on the FDA to Release the Names of Drugs Approved Using Fraudulent Data

Open Letter to the FDA: You’re Protecting the Wrong People

Suzanne B. Robotti

Heart Failure Drug Rejected, Rejected Again, Then Approved, What’s Up?

MedShadow Articles

Heart Failure Drug Rejected, Rejected Again, Then Approved, What’s Up?

Lamictal Interactions With Estrogen-Containing Drugs

FDA SIDE EFFECTS UPDATE: Lamictal Interactions With Estrogen-Containing Drugs, and More

Load More

x

x